Ticker LaunchIPO · BMGL
Basel Medical Group Ltd
Basel Medical Group Ltd (BMGL) priced its initial public offering on Feb 25, 2025 at $4.00 per share, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $73.8M. Revere was lead-left underwriter. Sichenzia Ross Ference Carmel, Maples and Calder and Bayfront Law advised the company and Hunter Taubman Fischer & Li advised the underwriters.
- Status
- IPO
- Ticker
- BMGL
- Exchange
- Nasdaq Capital Market
- Priced
- Feb 25, 2025
- IPO price
- $4.00
- Market cap at IPO price
- $73.8M
- First filed
- Sep 13, 2024
- Underwriters
- Revere
- Company counsel
- Sichenzia Ross Ference Carmel, Maples and Calder and Bayfront Law
- Underwriters' counsel
- Hunter Taubman Fischer & Li
- Sector
- Healthcare
- Country / state
- Singapore
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Sep 13, 2024
- Latest amendment Feb 13, 2025
- Final prospectus (424B4) Feb 25, 2025
- All filings on EDGAR CIK 2004489
Other Healthcare IPOs in 2025
- Cuprina Holdings (Cayman) LTDCUPR · Apr 10, 2025 · $12M
- Advanced Biomed Inc.ADVB · Mar 6, 2025 · $6.6M
- Kestra Medical Technologies, Ltd.KMTS · Mar 6, 2025 · $202M
- DataMeds AI, Inc.WGRX · Feb 21, 2025 · $4M
- Beta Bionics, Inc.BBNX · Jan 31, 2025 · $204M
- Cellyan Biotechnology Co., LtdHKPD · Jan 15, 2025 · $5.6M